title: Detection of IMP metallo-β-lactamase in carbapenem-nonsusceptible Enterobacteriaceae and non-glucose-fermenting Gram-negative rods by immunochromatography assay.
abstract: Metallo-β-lactamases (MBLs) are transmissible carbapenemases of increasing prevalence in Gram-negative bacteria among health care facilities worldwide. Control of the further spread of these carbapenem-resistant bacteria relies on clinical microbiological laboratories correctly identifying and classifying the MBLs. In this study, we evaluated a simple and rapid method for detecting IMP, the most prevalent MBL in Japan. We used an immunochromatography (IC) assay for 181 carbapenem-nonsusceptible (CNS) (nonsusceptible to imipenem or meropenem) strains comprising 74 IMP-producing and 33 non-IMP-producing strains of non-glucose-fermenting Gram-negative rods (NFGNR), as well as 64 IMP-producing and 10 non-IMP-producing Enterobacteriaceae strains. The IC assay results were compared to those from the double-disk synergy test (DDST), the MBL Etest, and the modified Hodge test (MHT) (only for Enterobacteriaceae). The IMP type was confirmed by specific PCR and direct sequencing. The IC assay detected all of the IMP-type MBLs, including IMP-1, -2, -6, -7, -10, -11, -19, -20, and -22 and IMP-40, -41, and -42 (new types), with 100% specificity and sensitivity against all strains tested. Although the sensitivity and specificity values for the DDST and MHT were equivalent to those for the IC assay, the MBL Etest was positive for only 87% of NFGNR and 31% of Enterobacteriaceae due to the low MIC of imipenem, causing an indeterminate evaluation. These results indicated that the IC assay might be a useful alternative to PCR for IMP MBL detection screening.
authors.affiliation: Department of Infection Control Science, Faculty of Medicine, Juntendo University, Tokyo, Japan.
authors.forename: Shigeyuki
authors.initials: S
authors.lastname: Notake
authors.forename: Mari
authors.initials: M
authors.lastname: Matsuda
authors.forename: Kiyoko
authors.initials: K
authors.lastname: Tamai
authors.forename: Hideji
authors.initials: H
authors.lastname: Yanagisawa
authors.forename: Keiichi
authors.initials: K
authors.lastname: Hiramatsu
authors.forename: Ken
authors.initials: K
authors.lastname: Kikuchi
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001431:Bacteriological Techniques / Q000379:methods; D015780:Carbapenems / Q000494:pharmacology*; D002846:Chromatography, Affinity / Q000379:methods*; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000201:enzymology* / Q000235:genetics; D016905:Gram-Negative Bacterial Infections / Q000382:microbiology; D006801:Humans; D007564:Japan; D016133:Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D017422:Sequence Analysis, DNA; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000032:analysis* / Q000235:genetics
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D001618:beta-Lactamases
references.citation: Antimicrob Agents Chemother. 2012 Dec;56(12):6437-40
references.pmid: 23070158
references.citation: Antimicrob Agents Chemother. 2012 Jul;56(7):3481-91
references.pmid: 22547615
references.citation: J Clin Microbiol. 2011 Sep;49(9):3222-7
references.pmid: 21775535
references.citation: J Clin Microbiol. 2002 Aug;40(8):2755-9
references.pmid: 12149325
references.citation: Nihon Rinsho. 2012 Feb;70(2):187-91
references.pmid: 22413516
references.citation: J Microbiol Methods. 2011 Dec;87(3):330-7
references.pmid: 21986031
references.citation: Diagn Microbiol Infect Dis. 2011 May;70(1):119-23
references.pmid: 21398074
references.citation: Diagn Microbiol Infect Dis. 2012 Sep;74(1):88-90
references.pmid: 22727768
references.citation: Lancet Infect Dis. 2011 May;11(5):381-93
references.pmid: 21530894
references.citation: Environ Microbiol. 2010 Jun;12(6):1513-30
references.pmid: 20192968
references.citation: Antimicrob Agents Chemother. 1991 Jan;35(1):147-51
references.pmid: 1901695
references.citation: J Clin Microbiol. 2004 Nov;42(11):5256-63
references.pmid: 15528723
references.citation: J Clin Microbiol. 2007 Jun;45(6):2034-6
references.pmid: 17409217
references.citation: J Clin Microbiol. 2000 Jan;38(1):40-3
references.pmid: 10618060
references.citation: Clin Microbiol Rev. 2005 Apr;18(2):306-25
references.pmid: 15831827
references.citation: Clin Microbiol Infect. 2012 Nov;18(11):1097-103
references.pmid: 22085042
references.citation: J Clin Microbiol. 2012 Dec;50(12):3877-80
references.pmid: 22993175
references.citation: J Clin Microbiol. 2003 Dec;41(12):5407-13
references.pmid: 14662918
references.citation: Clin Microbiol Infect. 2010 Feb;16(2):112-22
references.pmid: 20085605
references.citation: Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents
references.pmid: 17630334
references.citation: J Clin Microbiol. 2011 Mar;49(3):887-92
references.pmid: 21209160
references.citation: J Clin Microbiol. 2010 Apr;48(4):1445-9
references.pmid: 20181894
references.citation: Clin Microbiol Infect. 2012 May;18(5):432-8
references.pmid: 22507110
references.citation: J Antimicrob Chemother. 2008 Mar;61(3):548-53
references.pmid: 18222954
references.citation: Int J Antimicrob Agents. 2010 Sep;36(3):205-10
references.pmid: 20598859
references.citation: Antimicrob Agents Chemother. 1999 Apr;43(4):902-6
references.pmid: 10103197
references.citation: Antimicrob Agents Chemother. 2004 Jul;48(7):2347-9
references.pmid: 15215079